A third gene that has been identified to be associated with cardiovascular disease by genome-wide scanning is myocyte enhancing factor 2A (MEF2A) on chromosome 15q26 (Wang, Fan et al. 2003). This evidence concerns the gene MEF2A and cardiovascular disorder.